๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

27 recruiting trials

for Significant Prostate Cancer

Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy NCT07710807NA1 site๐Ÿ“ Ankara Ankara Etlik City Hospital ยท Tests: Transrectal Cognitive Fusion Prostate Biopsy, Transperineal Cognitive Fusion Prostate Biopsy Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer NCT07492927n/a10 sites๐Ÿ“ Chicago๐Ÿ“ Lanzhou๐Ÿ“ Yinchuan Xijing Hospital INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis NCT07398690NA1 site๐Ÿ“ Seoul In Gab Jeong, MD ยท Tests: Diagnostic Procedure, Diagnostic Procedure Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer NCT06773598n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology NCT07432360n/a1 site๐Ÿ“ Sรฃo Paulo Virdx, Inc. Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial NCT06303622NA1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: MRI-USG fusion approach, Cognitive-guided approach EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality NCT03987633n/a1 site๐Ÿ“ Wolverhampton Future Genetics Limited Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging NCT07369570NA1 site๐Ÿ“ Kuopio University of Eastern Finland ยท Tests: MRI The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA) NCT06867588NA1 site๐Ÿ“ Brussels Jules Bordet Institute ยท Tests: PSMA PET Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer NCT07553780n/a9 sites๐Ÿ“ Lanzhou๐Ÿ“ Yinchuan๐Ÿ“ Xining Xijing Hospital Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer NCT07180381NA7 sites๐Ÿ“ Emmen๐Ÿ“ Arnhem๐Ÿ“ Nijmegen St. Antonius Hospital ยท Tests: PSA and MRI-monitoring Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial NCT07164027EARLY Phase 11 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Biopsy of Prostate, Biospecimen Collection, Computed Tomography, Flotufolastat F-18 Gallium, Positron Emission Tomograpโ€ฆ The Development and Validation of MRI-AI-based Predictive Models for csPCa NCT06842264n/a1 site๐Ÿ“ Beijing Peking University First Hospital Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naรฏve Men With Suspected Prostate Cancer NCT07531329n/a9 sites๐Ÿ“ Lanzhou๐Ÿ“ Yinchuan๐Ÿ“ Xining Xijing Hospital ยท Tests: [โถโธGa]Ga-PSMA PET/CT with Delayed Pelvic PET-Only Acquisition Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer. NCT06305390Phase 21 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: PET/MRI Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 NCT06353321n/a1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: PET-CT imaging subsystem of the RefleXion X1 System Device Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance NCT07168616n/a10 sites๐Ÿ“ Istanbul๐Ÿ“ Ankara๐Ÿ“ Diyarbakฤฑr Istanbul University - Cerrahpasa ยท Tests: Ga-68 PSMA11 PET/CT Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis NCT07795723NA1 site๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: MRI/US Cognitive Fusion Targeted Biopsy Plus Ipsilateral Systematic Biopsy, MRI/US Cognitive Fusion Targeted Biopsy Pluโ€ฆ POSLUMAยฎ (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions NCT07220720Phase 21 site๐Ÿ“ Jacksonville University of Florida ยท Tests: Flotufolastat F 18 Decipher Lethal Prostate Cancer Biology - Urine Metabolomics NCT03237702NA1 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Multi-Carotenoids Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer NCT07863986n/a1 site๐Ÿ“ Kaunas Lithuanian University of Health Sciences ยท Tests: [177Lu]Lu-PSMA-617 (Pluvicto, Novartis), 68Ga-PSMA-11 PET/CT, Post-therapy 177Lu-PSMA SPECT/CT dosimetry, Circulating tโ€ฆ Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System NCT07109427NA1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Annual PSA Health Maintenance Reminder Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction NCT07614256n/a1 site๐Ÿ“ Liuzhou Guangxi Medical University ยท Tests: No Intervention: Observational Cohort Radical Prostatectomy Without Prior Biopsy NCT07819760NA1 site๐Ÿ“ Moscow Botkin Hospital ยท Tests: Transperineal Fusion-Targeted Prostate Biopsy With Intraoperative Frozen Section Examination, Robot-Assisted Radical Prโ€ฆ Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer NCT06579911NA1 site๐Ÿ“ Salzburg Salzburger Landeskliniken ยท Tests: High-frequency micro-ultrasound target biopsy, conventional Multiparametric MRT target biopsy Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions NCT06774781n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Whole Body MRI in Oncology NCT06895291n/a3 sites๐Ÿ“ Bologna๐Ÿ“ Meldola๐Ÿ“ Milan Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRโ€ฆ ยท Tests: Whole Body-Magnetic Resonance Imaging (WB-MRI)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy